Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in decompensated chronic heart failure
NCT00048425Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Sep 2002
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of levosimendan in chronic heart failure (CHF), sponsored by Abbott Laboratories. Started Sep 2002; status: completed.
02
Drugs
levosimendan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT00048425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048425.